Mary Paniaqua

Suggest Changes
Learn More
PURPOSE We investigated the ability of pretreatment with buthionine sulfoximine (BSO) to overcome a priori resistance to arsenic trioxide (As(2)O(3)) in multiple myeloma (MM) cells and determine(More)
  • 1